Klinische Wochenschrift

, Volume 65, Issue 22, pp 1104–1107 | Cite as

Reversible functional asplenia and subcapsular liver hematoma — Two distinctive manifestations of amyloidosis

  • E. Levy-Lahad
  • D. Steiner-Salz
  • N. Berkman
  • R. Chisin
  • P. Levensart
  • E. Leitersdorf


We hereby describe a patient with amyloidosis complicated by reversible functional asplenia and spontaneous rupture of the liver with subcapsular hematoma which resolved completely with conservative therapy. These two rare findings may result from extensive vascular amyloid in this patient.

Key words

Amyloidosis Splenic diseases Liver diseases 



Computerized tomography


Fibrin degradation products


Gamma glutamyl transferase




Leukocyte alkaline phosphatase


Lactic dehydrogenase


Prothrombin time


Partial thromboplastin time


Aspartate aminotransferase


Alanine aminotransferase


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bowie EJW, Maldonado JE, Brown AL, Didisheim P, Owen CA Jr (1969) Intravascular coagulation on systemic amyloidosis. Thromb Diath Haemorrh [Suppl] 36:305–312Google Scholar
  2. 2.
    Boyko WJ, Pratt R, Wass H (1982) Functional hyposplenism, a diagnostic clue in amyloidosis: report of six cases. Am J Clin Pathol 77:745–748Google Scholar
  3. 3.
    Coleman RE Functional asplenia. In: (eds) Nuclear radiology (3rd series) Syllabus. Chicago, American College of Radiology, pp 326–329Google Scholar
  4. 4.
    Furie B, Greene E, Furie BC (1977) Syndrome of acquired factor X deficiency and systemic amyloidosis: in vivo studies of the metabolic fate of factor X. N Engl J Med 297:81–85Google Scholar
  5. 5.
    Furie B, Voo I, McAdam KPW, Furie BC (1981) Mechanism of factor X deficiency in systemic amyloidosis. N Engl J Med 304:827–830Google Scholar
  6. 6.
    Galbraith PA, Sharma N, Parker WL, Kilgour J (1974) Acquired factor X deficiency: altered plasma antithrombin activity and association with amyloidosis. JAMA 230:1658–1660Google Scholar
  7. 7.
    Gertz MA, Kyle RA, Greipp PR (1983) Hyposplenism in primary systemic amyloidosis. Ann Intern Med 98:475–477Google Scholar
  8. 8.
    Glenner GG (1980) Amyloid deposits and amyloidosis: the beta-fibriloses. N Engl J Med 302:1283–1292Google Scholar
  9. 9.
    Greipp PR, Kyle RA, Bowie EJW (1979) Factor X deficiency in primary amyloidosis: resolution after splenectomy. N Engl J Med 301:1050–1051Google Scholar
  10. 10.
    Greipp PR, Kyle RA, Bowie EJW (1981) Factor X deficiency in amyloidosis: a critical review. Am J Hematol 11:443–450Google Scholar
  11. 11.
    Hurd WW, Katholi RE (1980) Acquired functional asplenia. Association with spontaneous rupture of the spleen and fatal spontaneous rupture of the liver in amyloidosis. Arch Intern Med 140:844–845Google Scholar
  12. 12.
    Kapp JP (1965) Hepatic amyloidosis with portal hypertension. JAMA 191:497–499Google Scholar
  13. 13.
    Kyle RA, Bayrd E (1975) Amyloidosis: review of 236 cases. Medicine 54:271–299Google Scholar
  14. 14.
    Kyle RA, Greipp PR (1983) Amyloidosis (AL): clinical and laboratory features in 229 cases. Mayo Clin Proc 58:665–683Google Scholar
  15. 15.
    Levine RA (1962) Amyloid disease of the liver. Am J Med 33:349–357Google Scholar
  16. 16.
    Levy M, Polliack A, Lender M, Eliakim M (1974) The liver in amyloidosis. Digestion 10:41–51Google Scholar
  17. 17.
    Liebman H, Chinowsky M, Vladin J, Kenoyer G, Feinstein D (1983) Increased fibrinolysis and amyloidosis. Arch Intern Med 143:678–682Google Scholar
  18. 18.
    Mcpherson RA, Onstad JW, Ugoretz RJ, Wolf PL (1977) Coagulopathy in amyloidosis: combined deficiency of factors IX and X. Am J Hematol 3:225–235Google Scholar
  19. 19.
    Meyer K, Williams EC (1985) Fibrinolysis and acquired alpha-2 plasmin inhibitor deficiency in amyloidosis. Am J Med 79:394–396Google Scholar
  20. 20.
    Polliack A, Hershko C (1972) Spontaneous rupture of the spleen in amyloidosis. Isr J Med Sci 8:57–60Google Scholar
  21. 21.
    Rubinow A, Koff RS, Cohen AS (1978) Severe intrahepatic cholestasis in primary amyloidosis: a report of four cases and a review of the literature. Am J Med 64:937–946Google Scholar
  22. 22.
    Spencer RP, Dhawan V, Suresh K, Antar MA, Sziklas JJ, Wasserman I (1978) Causes and temporal sequence of onset of functional asplenia in adults. Clin Nucl Med 3:17–18Google Scholar
  23. 23.
    Wilson H, Yawn DH (1979) Rupture of the spleen in amyloidosis. JAMA 241:790–791Google Scholar
  24. 24.
    Yood RA, Skinner M, Rubinow A, Talarico L, Cohen AS (1983) Bleeding manifestations in 100 patients with amyloidosis. JAMA 249:1322–1324Google Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • E. Levy-Lahad
    • 1
  • D. Steiner-Salz
    • 1
  • N. Berkman
    • 1
  • R. Chisin
    • 2
  • P. Levensart
    • 3
  • E. Leitersdorf
    • 1
  1. 1.Department of Medicine BHadassah University HospitalJerusalemIsrael
  2. 2.Department of Medical Biophysics and Nuclear MedicineHadassah University HospitalJerusalemIsrael
  3. 3.Department of RadiologyHadassah University HospitalJerusalemIsrael

Personalised recommendations